Distinctiveness And Likelihood Of Confusion In Pharmaceutical Trademarks: Critical Analysis Of Section 9(1) And 11(1) Of The Trade Marks Act, 1999
Updated: Nov 1
Ayush Upadhyay, B.B.A. LL.B. (H), Sister Nivedita University, Kolkata
Dhiraj Sau, B.B.A. LL.B. (H), Sister Nivedita University, Kolkata
ABSTRACT
Pharmaceutical trademarks raise concerns that differ from those associated with ordinary consumer products. Where two pharmaceutical marks are too similar, the confusion may extend beyond the marketplace and result in medication errors that endanger patients. This paper examines the issue under Sections 9(1) and 11(1) of the Trade Marks Act, 1999, with attention to distinctiveness and the likelihood of confusion between competing marks. The paper sets out the separate purposes of the two provisions. Section 9(1) concerns the absolute grounds for refusal, including the absence of distinctive character, while Section 11(1) concerns the relative grounds arising from similarity to an earlier mark. It then considers how questions of distinctiveness, deceptive similarity and likelihood of confusion arise together in pharmaceutical disputes. The discussion addresses visually and phonetically similar marks, particularly Look-Alike/Sound-Alike (LASA) names, and the reasons pharmaceutical products call for closer scrutiny than other goods. Cadila Healthcare Ltd. v. Cadila Pharmaceuticals Ltd., forms a significant portion of the analysis focusing on the concept of imperfect recollection when assessing confusion between pharmaceutical marks. It also evaluates the role of doctors, physicians and consumers while regulating fair competition and public interest. Even though Section 9(1) and 11(1) showcases different grounds for recusal but most of their traits appear to be closely interconnected with one other. As a result, a content specific approach would be deemed necessary to protect the rights of trademark holders without compromising consumer safety.
Keywords: Pharmaceutical Trademarks; Distinctiveness; Likelihood of Confusion; Section 9(1); Section 11(1).
